| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00277-016-2664-4 |
| P698 | PubMed publication ID | 27068405 |
| P2093 | author name string | Amer M Zeidan | |
| Maximilian Stahl | |||
| David P Steensma | |||
| Raajit Rampal | |||
| Mina L Xu | |||
| Melissa Much | |||
| P2860 | cites work | Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML | Q27852275 |
| Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia | Q33417454 | ||
| ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia | Q33421772 | ||
| CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. | Q33909621 | ||
| Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms | Q36946576 | ||
| Somatic SETBP1 mutations in myeloid malignancies | Q37060418 | ||
| The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment | Q37151676 | ||
| Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice | Q38312939 | ||
| Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib | Q87134157 | ||
| P433 | issue | 7 | |
| P921 | main subject | chronic neutrophilic leukemia | Q1088057 |
| ruxolitinib | Q7383611 | ||
| P304 | page(s) | 1197-1200 | |
| P577 | publication date | 2016-04-11 | |
| P1433 | published in | Annals of Hematology | Q15766509 |
| P1476 | title | Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia | |
| P478 | volume | 95 |
| Q47133078 | A t(1;9) translocation involving CSF3R as a novel mechanism in unclassifiable chronic myeloproliferative neoplasm. |
| Q89186094 | CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia |
| Q49959187 | CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival |
| Q42336327 | Changes in allele frequencies of CSF3R and SETBP1 mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib |
| Q49239291 | Chronic neutrophilic leukemia: new science and new diagnostic criteria |
| Q39059515 | Genomics of chronic neutrophilic leukemia |
| Q38684435 | JAK2 inhibitors for myeloproliferative neoplasms: what is next? |
| Q42695278 | Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia |
| Q48316140 | Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis |
| Q38712988 | Turning the tide in myelodysplastic/myeloproliferative neoplasms |
Search more.